Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Tossetta

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Antioxidants (Basel, Switzerland)|April 23, 2022
Role of NRF2 in Ovarian CancerGiovanni Tossetta, Sonia Fantone, Eva Montanari, et al.
Bone|February 8, 2022
The multifaced role of HtrA1 in the development of joint and skeletal disordersGiovanni Tossetta, Sonia Fantone, Caterina Licini, et al.
Molecular Biology Reports|March 26, 2025
Dose-dependent effects of curcumin on 22Rv1 prostate cancer cell lineGiovanni Tossetta, Sonia Fantone, Elena Marinelli Busilacchi, et al.
European Journal of Histochemistry : EJH|November 2, 2020
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular studySonia Fantone, Giovanni Tossetta, Rodolfo Montironi, et al.
Oncology Research|June 26, 2026
Resveratrol in Oral Squamous Cell Carcinoma: Preclinical Evidence and Translational OpportunitiesAlessandro Polizzi, Gaetano Isola, Monia Cecati, et al.
Molecular Diagnosis & Therapy|June 11, 2026
LINE-1 Deregulation in Ovarian Cancer: Implications for Diagnosis, Prognosis, and Therapeutic TargetingNicoletta Bonci, Valentina Schiavoni, Jesmina Rexha, et al.
Journal of Anatomy|January 31, 2023
ZO-1 expression in normal human macula densa: Immunohistochemical and immunofluorescence investigationsGiovanni Tossetta, Sonia Fantone, Martina Senzacqua, et al.
Acta Histochemica|January 17, 2022
AT-rich interactive domain 1A (ARID1A) cannot be considered a morphological marker for prostate cancer progression: A pilot studyGiovanni Tossetta, Sonia Fantone, Rosaria Gesuita, et al.
Tissue & Cell|June 22, 2026
Trophoblast cell-surface antigen 2 evaluation in intraepithelial neoplasia and intraductal carcinoma of the prostate: An immunopathological studySonia Fantone, Giovanni Tossetta, Francesca Sanguedolce, et al.
Human Cell|October 23, 2025
Psoriasis and lichen planus: an immunohistochemical study of Trophoblast cell-surface antigen 2 expression in skin biopsiesGiovanni Tossetta, Sonia Fantone, Alessandra Filosa, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Antioxidants (Basel, Switzerland)|April 23, 2022
Role of NRF2 in Ovarian CancerGiovanni Tossetta, Sonia Fantone, Eva Montanari, et al.
Bone|February 8, 2022
The multifaced role of HtrA1 in the development of joint and skeletal disordersGiovanni Tossetta, Sonia Fantone, Caterina Licini, et al.
Molecular Biology Reports|March 26, 2025
Dose-dependent effects of curcumin on 22Rv1 prostate cancer cell lineGiovanni Tossetta, Sonia Fantone, Elena Marinelli Busilacchi, et al.
European Journal of Histochemistry : EJH|November 2, 2020
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular studySonia Fantone, Giovanni Tossetta, Rodolfo Montironi, et al.
Oncology Research|June 26, 2026
Resveratrol in Oral Squamous Cell Carcinoma: Preclinical Evidence and Translational OpportunitiesAlessandro Polizzi, Gaetano Isola, Monia Cecati, et al.
Molecular Diagnosis & Therapy|June 11, 2026
LINE-1 Deregulation in Ovarian Cancer: Implications for Diagnosis, Prognosis, and Therapeutic TargetingNicoletta Bonci, Valentina Schiavoni, Jesmina Rexha, et al.
Journal of Anatomy|January 31, 2023
ZO-1 expression in normal human macula densa: Immunohistochemical and immunofluorescence investigationsGiovanni Tossetta, Sonia Fantone, Martina Senzacqua, et al.
Acta Histochemica|January 17, 2022
AT-rich interactive domain 1A (ARID1A) cannot be considered a morphological marker for prostate cancer progression: A pilot studyGiovanni Tossetta, Sonia Fantone, Rosaria Gesuita, et al.
Tissue & Cell|June 22, 2026
Trophoblast cell-surface antigen 2 evaluation in intraepithelial neoplasia and intraductal carcinoma of the prostate: An immunopathological studySonia Fantone, Giovanni Tossetta, Francesca Sanguedolce, et al.
Human Cell|October 23, 2025
Psoriasis and lichen planus: an immunohistochemical study of Trophoblast cell-surface antigen 2 expression in skin biopsiesGiovanni Tossetta, Sonia Fantone, Alessandra Filosa, et al.
Pageof 8